have the sheep gone to nz, page-3

The bright prospects of CAU have not changed.
Negative market sentiment towards the market in general and more so the biotech industry prevails.
CAU is on track to secure its first sales this month.
The risks associated with the completion and commisioning of their plant has dissipated.
Potential sales are the only unknown quantity and if you are familiar with CAU's world class product you would come to the conclusion that sales are imminent and a high probability.
I put fair value at present at 29c with upside potential in the next 6 months at upward of 50c.
This is a bargain basement buy at these levels.
The top 20 shareholders hold over 50% of the company and have not decresed their holdings.
I continue to hold and increase my holding.
Expecting confirmation of successful despatch of samples next week.
Good luck!